Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.

CONCLUSION: This large safety cohort confirms the efficacy, safety and tolerability of Cystadrops in real-world clinical practice.
PMID: 32593979 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - June 26, 2020 Category: Opthalmology Authors: Liang H, Labbé A, Baudouin C, Plisson C, Giordano V Tags: Br J Ophthalmol Source Type: research